| Cover | 1 |
---|
| Front matter | 4 |
---|
| Contents | 6 |
---|
| Preface | 8 |
---|
| Sonography of Normal and Abnormal Thyroid and Parathyroid Glands | 10 |
---|
| Abstract | 10 |
| Thyroid Ultrasonography | 11 |
| Parathyroid Ultrasonography | 20 |
| References | 23 |
| Computed Tomography and Magnetic Resonance Imaging of the Thyroid and Parathyroid Glands | 25 |
---|
| Abstract | 25 |
| Thyroid | 25 |
| Parathyroid | 28 |
| References | 31 |
| Role of Nuclear Medicine in the Diagnosis of Benign Thyroid Diseases | 33 |
---|
| Abstract | 33 |
| Nuclear Medicine: Radiopharmacology and Methods | 34 |
| Devices | 34 |
| Radiopharmaceuticals | 35 |
| Technetium-99m | 35 |
| Measurement of Technetium Uptake | 35 |
| Iodine Isotopes: 123 I and 131 I | 35 |
| Measurement of Iodine Uptake | 36 |
| Thyroid Scintigraphy | 36 |
| Other Thyroid Examinations and Tests | 37 |
| Benign Thyroid Diseases and Indications for Nuclear Medicine Tests | 40 |
| Acknowledgements | 44 |
| References | 44 |
| Hybrid Molecular Imaging in Differentiated Thyroid Carcinoma | 46 |
---|
| Abstract | 46 |
| The Use of Radioiodine in Thyroid Carcinomas | 47 |
| Single-Photon Emission Computed Tomography/Computed Tomography in Differentiated Thyroid Carcinoma | 49 |
| Position Emission Tomography/Computed Tomography in Differentiated Thyroid Carcinoma | 51 |
| Conclusions | 52 |
| References | 53 |
| Endoscopic Ultrasound in Endocrinology: Imaging of the Adrenals and the Endocrine Pancreas | 55 |
---|
| Abstract | 55 |
| Technical Details | 56 |
| Resolution | 57 |
| Indications and Typical Findings | 57 |
| Conclusion | 62 |
| References | 62 |
| Adrenal Imaging: Magnetic Resonance Imagingand Computed Tomography | 64 |
---|
| Abstract | 64 |
| Introduction | 64 |
| Benign Lesions | 70 |
| Malignant Lesions | 73 |
| Image-Guided Intervention | 75 |
| References | 77 |
| Adrenal Molecular Imaging | 79 |
---|
| Abstract | 79 |
| Molecular Imaging Techniques | 80 |
| Adrenal Incidentalomas | 81 |
| Molecular Imaging of Adrenal Tumors | 82 |
| Primary Aldosteronism | 83 |
| 11 C-Metomidate PET in Adrenocortical Cancer | 83 |
| 123 I-Metomidate SPECT | 84 |
| Pheochromocytoma | 84 |
| References | 87 |
| Gonadal Imaging in Endocrine Disorders | 89 |
---|
| Abstract | 89 |
| Male Gonads | 89 |
| Female Gonads | 97 |
| References | 104 |
| Magnetic Resonance Imaging of Pituitary Tumors | 106 |
---|
| Abstract | 106 |
| The Normal Pituitary Gland | 106 |
| Pituitary Adenomas | 108 |
| Collision Lesions of the Pituitary Region | 120 |
| The Postoperative Sella | 120 |
| Differential Diagnosis of Sellar Space-Occupying Lesions | 123 |
| References | 128 |
| Intraoperative Magnetic Resonance Imaging for Pituitary Adenomas | 130 |
---|
| Abstract | 130 |
| Scanners and Setups | 131 |
| Results of Low-Field Studies | 133 |
| Results of High-Field Studies | 135 |
| Use of Neuronavigation | 136 |
| Intraoperative Imaging and Endoscopic Surgery | 139 |
| Conclusions | 139 |
| References | 139 |
| Molecular Imaging of Pituitary Pathology | 142 |
---|
| Abstract | 142 |
| Receptor Imaging of Pituitary Tumors | 143 |
| Dopamine D2 Receptor Imaging of Pituitary Adenomas | 143 |
| Dopamine D2 Receptor Imaging of Pituitary Carcinomas | 143 |
| Somatostatin Receptor Scintigraphy of Pituitary Disorders | 144 |
| 18F-Fluorodeoxy-D-Glucose Positron EmissionTomography and Pituitary Pathology | 147 |
| L - 11 C-Methionine Positron Emission Tomography and Pituitary Pathology | 149 |
| Conclusions | 149 |
| References | 149 |
| Imaging of Neuroendocrine Tumors | 151 |
---|
| Abstract | 151 |
| Imaging Techniques | 152 |
| Neuroendocrine Tumor Characteristics, Presentationand Image Findings | 156 |
| Imaging in Therapy Monitoring | 158 |
| References | 159 |
| Author Index | 161 |
---|
| Subject Index | 162 |
---|
| Cover | 166 |